Cargando…
A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness among older adults in the Western world. While therapies exist for patients with exudative AMD, there are currently no approved therapies for non-exudative AMD and its advanced form of geographic atrophy (GA). The di...
Autores principales: | Halawa, Omar A., Lin, Jonathan B., Miller, Joan W., Vavvas, Demetrios G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230644/ https://www.ncbi.nlm.nih.gov/pubmed/34208067 http://dx.doi.org/10.3390/jcm10122580 |
Ejemplares similares
-
Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results
por: Lin, Jonathan B., et al.
Publicado: (2021) -
Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Systematic Review
por: Lin, Jonathan B., et al.
Publicado: (2022) -
Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
por: Lin, Jonathan B., et al.
Publicado: (2022) -
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
por: Boyer, David S., et al.
Publicado: (2017) -
C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration
por: Yednock, Ted, et al.
Publicado: (2022)